Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes
暂无分享,去创建一个
J. Staessen | R. Fagard | R. Vlietinck | F. Soubrier | Ji G. Wang | G. Ginocchio | Arturo P. Saavedra | J. G. Wang | J. -. Wang
[1] J. Staessen,et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.
[2] G. Kajiyama,et al. Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. , 1997, American journal of hypertension.
[3] W. Sheu,et al. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension , 1997, Journal of hypertension.
[4] Y. Ko,et al. Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese , 1997, Human Genetics.
[5] P. Amouyel,et al. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. , 1997, Circulation.
[6] U. Ikeda,et al. Angiotensin converting enzyme gene polymorphism in essential hypertension based on ambulatory blood pressure monitoring. , 1997, American journal of hypertension.
[7] A. Gharavi,et al. Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension. , 1997, American journal of hypertension.
[8] P. Amouyel,et al. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. , 1997, Heart.
[9] T. Sørensen,et al. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. , 1997, Circulation.
[10] C. Rotimi,et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.
[11] H. Kawasaki,et al. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. , 1997, Life sciences.
[12] A. Distler,et al. Genetic variants of the renin–angiotensin system and ambulatory blood pressure in essential hypertension , 1997, Journal of hypertension.
[13] G Chatellier,et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.
[14] I. Unsal,et al. Angiotensin converting enzyme gene polymorphism and the risk and extent of ischemic heart disease among Turkish patients. , 1997, Coronary artery disease.
[15] P. Amouyel,et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. , 1997, Journal of the American College of Cardiology.
[16] F. Perticone,et al. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. , 1997, Journal of the American College of Cardiology.
[17] R. Ward,et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension , 1997, Journal of Human Hypertension.
[18] I. Borecki,et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. , 1997, Annals of epidemiology.
[19] I. Borecki,et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. , 1997, Annals of epidemiology.
[20] K. Thai,et al. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. , 1997, Kidney international.
[21] R. Kunz,et al. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension , 1997, Diabetologia.
[22] P. Ducimetiere,et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study , 1996, Human Genetics.
[23] R. Zulli,et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. , 1996, Hypertension.
[24] S. Ito,et al. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies , 1996, Journal of hypertension.
[25] D. Levy,et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. , 1996, The New England journal of medicine.
[26] A. Rantala,et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis , 1996, Journal of hypertension.
[27] Y. Friedlander,et al. M235→ T polymorphism of the angiotensinogen gene predicts hypertension in the elderly , 1996, Journal of hypertension.
[28] A. Maxwell,et al. A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM , 1996, Diabetes.
[29] E. Schwartz,et al. Absence of association between the angiotensin-converting enzyme gene polymorphism and borderline hypertension in men of St Petersburg, Russia. , 1996, Journal of human hypertension.
[30] Y. Yazaki,et al. Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. , 1996, Coronary artery disease.
[31] H. Schunkert,et al. Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sample. , 1996, Journal of hypertension.
[32] M. Ishida,et al. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. , 1996, Hypertension.
[33] G. MacGregor,et al. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. , 1996, Kidney international.
[34] B. Julian,et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. , 1996, Kidney international.
[35] J. Ménard,et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.
[36] S. Douma,et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. , 1995, American journal of hypertension.
[37] M. Stowasser,et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. , 1996, Journal of human hypertension.
[38] P. Talmud,et al. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? , 1995, Circulation.
[39] M. Offidani,et al. Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low‐risk population , 1995, Journal of hypertension.
[40] J. Critchley,et al. Angiotensin converting enzyme insertion-deletion polymorphism in Chinese. , 1995, Journal of hypertension.
[41] J. Staessen,et al. Heritability of conventional and ambulatory blood pressures. A study in twins. , 1995, Hypertension.
[42] E. Arbustini,et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. , 1995, British heart journal.
[43] N. Hübner,et al. Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical complex phenotypes in human and rat hypertension. , 1995, Circulation.
[44] C. Ponticelli,et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] I. Ichikawa,et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.
[46] H. Markus,et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.
[47] M. Caulfield,et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. , 1995, The Journal of clinical investigation.
[48] F. Cambien,et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. , 1995, Hypertension.
[49] K. Kario,et al. Effect of the angiotensinogen gene Met235$Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations , 1995, Journal of hypertension.
[50] J. Connell,et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.
[51] K. Lindpaintner,et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. , 1995, Circulation.
[52] J. Higaki,et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. , 1995, Hypertension.
[53] H. Parving,et al. Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients , 1995, Diabetes.
[54] N. Iwai,et al. Angiotensinogen gene and blood pressure in the Japanese population. , 1995, Hypertension.
[55] R Kreutz,et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.
[56] T. Iwamoto,et al. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. , 1995, American journal of hypertension.
[57] R. Hegele,et al. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. , 1994, Circulation.
[58] K. Nakai,et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. , 1994, Circulation.
[59] C. Rotimi,et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. , 1994, Hypertension.
[60] M. Perola,et al. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. , 1994, The American journal of physiology.
[61] P. Munroe,et al. ACE insertion/deletion (I/D) polymorphism in Vincentian African Caribbeans with essential hypertension. , 1994, Journal of human hypertension.
[62] G. Sagnella,et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin , 1994, Journal of hypertension.
[63] N. Markandu,et al. Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population. , 1994, Journal of human hypertension.
[64] L. Tiret,et al. Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.
[65] P. Kubilis,et al. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. , 1994, American journal of hypertension.
[66] T. Ogihara,et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. , 1994, Journal of human hypertension.
[67] H. Schunkert,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[68] A. Krolewski,et al. Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene , 1994, Diabetes.
[69] F. Cambien,et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[70] F. Cambien,et al. Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications , 1994, Diabetes.
[71] J. Lalouel,et al. Angiotensinogen as a risk factor for essential hypertension in Japan. , 1994, The Journal of clinical investigation.
[72] Y. Michishita,et al. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients , 1994, The Lancet.
[73] T. Morise,et al. Angiotensin-converting enzyme polymorphism and essential hypertension , 1994, The Lancet.
[74] Yasuyuki Nakamura,et al. Molecular Variants of the Angiotensinogen Gene and Hypertension in a Japanese Population , 1994 .
[75] P. Froguel,et al. Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.
[76] J. Erikssen,et al. Insertion /deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and parental history of myocardial infarction , 1993, Clinical genetics.
[77] T. Ogihara,et al. A potent genetic risk factor for restenosis , 1993, Nature Genetics.
[78] T. Beaty,et al. Fundamentals of Genetic Epidemiology , 1993 .
[79] D. Grobbee,et al. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study , 1993, Journal of hypertension.
[80] O. Costerousse,et al. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.
[81] A. Wilkie. Medical genetics: advances in brief , 1993 .
[82] A. Riches,et al. The mechanism of action of the tetrapeptide Acetyl‐N‐Ser‐Asp‐Lys‐Pro (AcSDKP) in the control of haematopoietic stem cell proliferation , 1992, Cell proliferation.
[83] U. Ravnskov,et al. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. , 1992, BMJ.
[84] P. C. White,et al. Genetic analysis of the human type-1 angiotensin II receptor. , 1992, Molecular endocrinology.
[85] H. Dustan. Growth factors and racial differences in severity of hypertension and renal diseases , 1992, The Lancet.
[86] B. Morris,et al. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. , 1992, Biochemical and biophysical research communications.
[87] F. Soubrier,et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.
[88] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[89] C. Grim,et al. Biohistory of Slavery and Blood Pressure Differences in Blacks Today A Hypothesis , 1991, Hypertension.
[90] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[91] N. Poulter,et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. , 1990, BMJ.
[92] B. Morris,et al. Frequency in hypertensives of alleles for a RFLP associated with the renin gene. , 1988, Biochemical and biophysical research communications.
[93] S. Srinivasan,et al. Black-white contrasts as determinants of cardiovascular risk in childhood: precursors of coronary artery and primary hypertensive diseases. , 1984, American heart journal.